Article Versions Notes

Griguolo G, Brasó-Maristany F, González-Farré B, Pascual T, Chic N, Saurí T, Kates R, Gluz O, Martínez D, Paré L, et al. ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. Cancers. 2020; 12(7):1902. https://doi.org/10.3390/cancers12071902

Griguolo, Gaia, Fara Brasó-Maristany, Blanca González-Farré, Tomás Pascual, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, and et al. 2020. "ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer" Cancers 12, no. 7: 1902. https://doi.org/10.3390/cancers12071902

Griguolo, G., Brasó-Maristany, F., González-Farré, B., Pascual, T., Chic, N., Saurí, T., Kates, R., Gluz, O., Martínez, D., Paré, L., Tsvetkova, V., Pesantez, D., Vidal, M., Adamo, B., Muñoz, M., Galván, P., Barberá, L., Cuatrecasas, M., Christgen, M., ... Prat, A. (2020). ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. Cancers, 12(7), 1902. https://doi.org/10.3390/cancers12071902